UBS raised the firm’s price target on Vistra (VST) to $160 from $154 and keeps a Buy rating on the shares. Vistra delivered positive Q1 results and commentary around 2026 EBITDA, the analyst tells investors in a research note. The firm expects completion of the Texas legislative session will remove a significant legal uncertainty with respect to signing long-term nuclear purchased power agreements in the Electric Reliability Council of Texas.